We do not rely on self-reported "wellness". We track biomarkers. Here is the comparative data for the Cortex Protocol vs. Standard of Care (SSRI/CBT).

Our audit tracks the Hamilton Depression Rating Scale (HAM-D) and the GAD-7 Anxiety scale. The synergy of biochemical priming (Ketamine) followed by electrical consolidation (TMS) produces outcomes significantly superior to monotherapy.

Remission Rates (HAM-D Score)

Standard of Care (SSRI Monotherapy)
35%
Cortex Protocol (Ketamine + TMS)
83%
Source: Internal Audit (N=500) vs STAR*D Trial Data

Relapse Rate (6 Months Post-Acute)

Standard of Care
60%
Cortex Protocol (with Maintenance)
12%

Methodology

Data reflects patients completing the full 14-day hybrid protocol. "Remission" is defined as a HAM-D score < 7.

References:
Full dataset anonymized and available for peer review.